{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:35:55Z","timestamp":1789763755420,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.eplepsyres.2005.08.004","type":"journal-article","created":{"date-parts":[[2005,10,3]],"date-time":"2005-10-03T09:40:34Z","timestamp":1128332434000},"page":"173-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Serum thyroid hormone balance and lipid profile in patients with epilepsy"],"prefix":"10.1016","volume":"66","author":[{"given":"Sherifa A.","family":"Hamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas A.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud R.","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala K.","family":"El-Shereef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa M.","family":"Abdellah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eplepsyres.2005.08.004_bib1","first-page":"282","article-title":"HDL-cholesterol\u2014active or passive participant in the pathogenesis of atherosclerosis","volume":"107","author":"Artenie","year":"2003","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib2","first-page":"83","article-title":"The IMMULITE 2000 Automated Immunoassay System","volume":"14","author":"Babson","year":"1991","journal-title":"J. Clin. Immunoassay"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0404.1983.tb04569.x","article-title":"Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate","volume":"67","author":"Bentsen","year":"1983","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib4","first-page":"356","article-title":"The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance","volume":"80","author":"Beshyah","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.eplepsyres.2005.08.004_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1152\/ajpheart.00580.2001","article-title":"Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults","volume":"282","author":"Bramswig","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2005.08.004_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0404.1991.tb04691.x","article-title":"Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital","volume":"83","author":"Calandre","year":"1991","journal-title":"Acta Neurol. Scand."},{"issue":"12","key":"10.1016\/j.eplepsyres.2005.08.004_bib7","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1073\/pnas.96.12.6920","article-title":"Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice","volume":"96","author":"Caligiuri","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.eplepsyres.2005.08.004_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1081\/ERC-120025038","article-title":"Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism","volume":"29","author":"Canturk","year":"2003","journal-title":"Endocr. Res."},{"issue":"5\u20136","key":"10.1016\/j.eplepsyres.2005.08.004_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2298\/MPNS0306276C","article-title":"Dyslipidemia and subclinical hypothyroidism","volume":"56","author":"Caparevic","year":"2003","journal-title":"Med. Pregl."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib10","doi-asserted-by":"crossref","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy, 1989. Proposal for revised classification of epilepsies and patients with epilepsy syndromes. Epilepsia 30, 3890\u20133899.","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"issue":"4","key":"10.1016\/j.eplepsyres.2005.08.004_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00542140","article-title":"Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine","volume":"26","author":"Connell","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2005.08.004_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/JPEM.2003.16.2.193","article-title":"Effect of long-term carbamazepine therapy on serum lipids, Vitamin B12 and folic acid levels in children","volume":"16","author":"Deda","year":"2003","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.eplepsyres.2005.08.004_bib13","first-page":"746","article-title":"Thyroid disorders and dyslipidemias","volume":"54","author":"Deschampheleire","year":"1999","journal-title":"Rev. Med. Liege"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib14","unstructured":"Diagnostic Product Corporation, 1987. Albumin-Related Artifacts in Free Thyroid Hormone Assays. Los Angeles."},{"issue":"5","key":"10.1016\/j.eplepsyres.2005.08.004_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/07315724.2003.10719323","article-title":"Complex multivitamin supplementation improves homocysteine and resistance to LDL-c oxidation","volume":"22","author":"Earnest","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"issue":"6","key":"10.1016\/j.eplepsyres.2005.08.004_bib16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/WNL.45.6.1155","article-title":"Effects of long-term treatment with antipatients with epilepsy drugs on serum lipid levels in children with epilepsy","volume":"45","author":"Eiris","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib17","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1157.1999.tb01595.x","article-title":"Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism","volume":"40","author":"Eiris-Punal","year":"1999","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2005.08.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(00)00119-4","article-title":"The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy","volume":"41","author":"Eiris","year":"2000","journal-title":"Epilepsy Res."},{"issue":"6","key":"10.1016\/j.eplepsyres.2005.08.004_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1528-1157.1985.tb05697.x","article-title":"Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine, and valproic acid","volume":"26","author":"Ericsson","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1528-1157.1978.tb04498.x","article-title":"Effects of anticonvulsant drugs on thyroid hormones in patients with epilepsy children","volume":"19","author":"Fichsel","year":"1978","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2005.08.004_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1528-1157.1992.tb02203.x","article-title":"Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antipatients with epilepsy drugs","volume":"33","author":"Franzoni","year":"1992","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2005.08.004_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1096-4959(01)00416-X","volume":"130","author":"Geelen","year":"2001","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2005.08.004_bib23","first-page":"319","article-title":"Monitoring antiepiletptic drug therapy in Upper Egypt: a retrospective 6-years experience in carbamazepine","volume":"25","author":"Goma","year":"2004","journal-title":"J. Egypt Soc. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.eplepsyres.2005.08.004_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0021-9150(98)00278-0","article-title":"Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels","volume":"143","author":"Halle","year":"1999","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.eplepsyres.2005.08.004_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1254\/jphs.CRJ05003X","article-title":"The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins","volume":"98","author":"Hamed","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935\u20131984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2005.08.004_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2265.1985.tb01100.x","article-title":"Increased frequency of goitre in patients with epilepic patients on long-term phenytoin or carbamazepine treatment","volume":"23","author":"Hegedus","year":"1985","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2005.08.004_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/meta.2002.31323","article-title":"Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A\u2013I in the rat","volume":"51","author":"Huesca-Gomez","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib29","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1528-1157.1994.tb01792.x","article-title":"Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxacarbazepine","volume":"35","author":"Isojarvi","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1528-1157.1995.tb01619.x","article-title":"Thyroid and myocardial function after replacing carbamazepine by oxcarbazepine","volume":"36","author":"Isojarvi","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archneur.1989.00520470029021","article-title":"Thyroid function in patients with epilepsy patients treated with carbamazepine","volume":"46","author":"Isojarvi","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib32","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archneur.1990.00530060082023","article-title":"Serum hormones in male patients with epilepsy patients receiving anticonvulsant medication","volume":"47","author":"Isojarvi","year":"1990","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1046\/j.1528-1157.2001.042007930.x","article-title":"Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy","volume":"42","author":"Isojarvi","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib34","first-page":"411","article-title":"Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase\/NO system in atherosclerosis","volume":"4","author":"Jouko","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib35","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1528-1157.1992.tb01773.x","article-title":"Possible interaction between oxcarbazepine and an oral contraceptive","volume":"33","author":"Klosterskov Jensen","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2125.1991.tb03858.x","article-title":"Lack of enzyme induction with oxcarbazepine (600mg daily) in healthy subjects","volume":"31","author":"Larkin","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2265.1978.tb01493.x","article-title":"Thyroid function test in patients on long-term treatment with various anticonvulsant drugs","volume":"8","author":"Liewendahl","year":"1978","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2005.08.004_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000115130","article-title":"Plasma high-density lipoprotein cholesterol in patients with epilepsys treated with various anticonvulsants","volume":"19","author":"Luoma","year":"1980","journal-title":"Eur. Neurol."},{"issue":"6","key":"10.1016\/j.eplepsyres.2005.08.004_bib39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/00005344-198211000-00023","article-title":"Relationship between plasma high-density lipoprotein cholesterol and anticonvulsant levels in patients with epilepsys","volume":"4","author":"Luoma","year":"1982","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2005.08.004_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0009-8981(77)90215-7","article-title":"Hypothyroidism, an important cause of reversible hyperlipidemia","volume":"74","author":"Mishkel","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2265.2000.01104.x","article-title":"Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database","volume":"53","author":"Monson","year":"2000","journal-title":"Clin. Endocrinol."},{"issue":"159","key":"10.1016\/j.eplepsyres.2005.08.004_bib42","first-page":"785","article-title":"Serum lipids, lipoproteins, and apolipoproteins in adult patients with epilepsys treated with carbamazepine, valproic acid, or phenytoin","volume":"27","author":"Pita-Calandre","year":"1998","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib43","first-page":"193","article-title":"Hyposexuality: a complication of complex partial epilepsy","volume":"105","author":"Pritchard","year":"1980","journal-title":"Trans. Am. Neurol. Assoc."},{"issue":"3","key":"10.1016\/j.eplepsyres.2005.08.004_bib44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bms.1200180308","article-title":"Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic\/mass spectrometric techniques","volume":"18","author":"Rettenmeier","year":"1989","journal-title":"Biomed. Environ. Mass Spectrom."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib45","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrin."},{"issue":"11","key":"10.1016\/j.eplepsyres.2005.08.004_bib46","first-page":"643","article-title":"Subclinical hypothyroidism with emphasis on the cardiovascular system","volume":"142","author":"Spacilova","year":"2003","journal-title":"Cas. Lek. Cesk."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0404.1981.tb00754.x","article-title":"Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy","volume":"63","author":"Strandjord","year":"1981","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.eplepsyres.2005.08.004_bib48","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1528-1157.1999.tb00744.x","article-title":"Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study","volume":"40","author":"Sudhop","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.1996.03530430039036","article-title":"Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine","volume":"275","author":"Surks","year":"1996","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.eplepsyres.2005.08.004_bib50","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1651-2227.2002.tb02878.x","article-title":"Plasma homocysteine and lipoprotein (a) levels as risk factors for atherosclerotic vascular disease in patients with epilepsy children taking anticonvulsants","volume":"91","author":"Tumer","year":"2002","journal-title":"Acta Paediatr."},{"issue":"5","key":"10.1016\/j.eplepsyres.2005.08.004_bib51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0887-8994(98)00084-8","article-title":"Serum lipids and lipoproteins in patients treated with antipatients with epilepsy drugs","volume":"19","author":"Verrotti","year":"1998","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0887-8994(01)00279-X","article-title":"Thyroid hormones in patients with epilepsy children receiving carbamazepine and valproic acid","volume":"25","author":"Verrotti","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/07435808709035464","article-title":"Carbamazepine (Tegretol) inhibits in vivo iodide uptake and hormone synthesis in rat thyroid glands","volume":"13","author":"Villa","year":"1987","journal-title":"Endocr. Res."},{"issue":"4","key":"10.1016\/j.eplepsyres.2005.08.004_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1563-2571.2001.01022.x","article-title":"Possible consequences of subclinical hypothyroidism","volume":"30","author":"Weissel","year":"2003","journal-title":"Acta Med. Austriaca"},{"key":"10.1016\/j.eplepsyres.2005.08.004_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/clinchem\/34.1.9","article-title":"Chemically blocked analog assays for free thyronines. I. The effect of chemical blockers on T4 analog and T4 binding by albumin and by thyroxin-binding globulin","volume":"34","author":"Witherspoon","year":"1988","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.eplepsyres.2005.08.004_bib56","first-page":"217","article-title":"Serum lipid changes during anticonvulsive treatment serum lipids in patients with epilepsy children","volume":"101","author":"Yilmaz","year":"2001","journal-title":"Acta Neurol. Belg."},{"issue":"8","key":"10.1016\/j.eplepsyres.2005.08.004_bib57","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0026-0495(99)90204-4","article-title":"A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in patients with epilepsy patients receiving anticonvulsants","volume":"48","author":"Yoo","year":"1999","journal-title":"Metabolism"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121105001749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121105001749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:15:02Z","timestamp":1760274902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121105001749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":57,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0920121105001749"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.08.004","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum thyroid hormone balance and lipid profile in patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}